US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Voya Infrastructure Industrials and Materials Fund

11.71

+0.01910.16%

Post-market: 11.710.00000.00%15:40 EDT

Volume:21.90K

Turnover:256.22K

Market Cap:225.74M

PE:- -

High:11.71

Open:11.70

Low:11.69

Close:11.69

Loading ...

Overview Company News Filings

Press Release: ONWARD Medical Builds Commercial Momentum for the ARC-EX System and Reinforces its Brain-Computer Interface Leadership in Q1 2025

Press Release: VOYA GLOBAL ADVANTAGE AND PREMIUM OPPORTUNITY FUND & VOYA INFRASTRUCTURE, INDUSTRIALS AND MATERIALS FUND ANNOUNCES PAYMENT OF MONTHLY DISTRIBUTION

Voya Infrastructure Industrials and Materials Fund Releases June 2025 Distribution Report

Press Release: Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update

Press Release: VOYA GLOBAL ADVANTAGE AND PREMIUM OPPORTUNITY FUND & VOYA INFRASTRUCTURE, INDUSTRIALS AND MATERIALS FUND ANNOUNCES PAYMENT OF MONTHLY DISTRIBUTION

Artivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery (AATS) Annual Meeting

Commemorative NFT Easter Eggs to be Minted After Successful Exhibition of Patented Data Vault® Experiential Data Display in Washington D.C.

enVVeno Medical Reports First Quarter 2025 Financial Results and Reiterates Progress Toward VenoValve FDA Decision Expected in 2H24

ACCESS Newswire

BD Reports Second Quarter Fiscal 2025 Financial Results

Datavault AI Stockholders’ Majority Approve Strategic Acquisition of CompuSystems, Inc.

NFL Alumni Health Taps Datavault AI’s ADIO® for Health-Focused and Interactive Web 3.0 Activations During Draft Week Event

Microchip Introduces PIC16F17576 MCU Family to Simplify Analog Sensor Design

Press Release: Voya Equity Closed End Funds Declare Distributions

Press Release: VOYA GLOBAL ADVANTAGE AND PREMIUM OPPORTUNITY FUND & VOYA INFRASTRUCTURE, INDUSTRIALS AND MATERIALS FUND ANNOUNCES PAYMENT OF MONTHLY DISTRIBUTION

Comparative Analysis of Qubetics, SUI, and Binance Coin: Best Cryptos to Buy Right Now

Datavault AI to Participate at the LD Micro Invitational XV

Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma

ASE Demonstrates CPO that Improves Energy Efficiency for AI applications

ABT Stock Gains Following the Positive TRILUMINATE Trial Results

Fractyl Health Reports Positive Early Data Showing Revita® Has Potential to Prevent Weight Regain After GLP-1 Discontinuation

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/IDE/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IDE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDE\",,,,,undefined,":{"symbol":"IDE","market":"US","secType":"STK","nameCN":"Voya Infrastructure Industrials and Materials Fund","latestPrice":11.7091,"timestamp":1751562000000,"preClose":11.69,"halted":0,"volume":21900,"hourTrading":{"tag":"盘后","latestPrice":11.7091,"preClose":11.7091,"latestTime":"15:40 EDT","volume":243,"amount":2812.2264,"timestamp":1751571651521},"delay":0,"floatShares":0,"shares":19279000,"eps":0,"marketStatus":"Market Closed","change":0.0191,"latestTime":"07-03 13:00:00 EDT","open":11.7,"high":11.71,"low":11.69,"amount":256224.4812,"amplitude":0.001711,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1751875200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":11.69,"aum":0,"dividendRate":0.102484,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":11.7091,"preClose":11.7091,"latestTime":"15:40 EDT","volume":243,"amount":2812.2264,"timestamp":1751571651521},"volumeRatio":0.5525318665450013},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDE\",,,,,undefined,":{"symbol":"IDE","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.5525318665450013,"shares":19279000,"dividePrice":1.2,"high":11.71,"amplitude":0.001711,"preClose":11.69,"low":11.69,"week52Low":8.75,"pbRate":"--","week52High":11.766,"institutionHeld":0,"latestPrice":11.7091,"eps":0,"divideRate":0.102484,"volume":21900,"delay":0,"ttmEps":0,"open":11.7,"prevYearClose":10.15,"prevWeekClose":11.69,"prevMonthClose":11.69,"prevQuarterClose":11.69,"fiveDayClose":11.65,"twentyDayClose":11.36,"sixtyDayClose":9.1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDE\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2544932811","title":"Press Release: ONWARD Medical Builds Commercial Momentum for the ARC-EX System and Reinforces its Brain-Computer Interface Leadership in Q1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2544932811","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544932811?lang=en_us&edition=fundamental","pubTime":"2025-06-17 13:30","pubTimestamp":1750138200,"startTime":"0","endTime":"0","summary":"EINDHOVEN, the Netherlands, June 17, 2025  -- ONWARD Medical N.V. , the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury  and other movement disabilities, today announces its Q1 2025 business update and year-to-date highlights:. -- Commercial traction: Following FDA market authorization, the Company met. its Q1 objective for the limited initial phase of its US launch of the. ARC-EX System, hiring, training and deploying a field organization,establishing a sales and service process, building a roster of reference. -- Technology advancement: The Company's investigational ARC-IM and. ARC-BCI platforms reached new milestones with the 4th and 5th. successful BCI implants to restore thought-driven movement, and the first. human implant of its investigational ARC-IM Lumbar Lead, which is. supporting the ARC-EX System, Pathfinder2 study results published in. In the first quarter, ONWARD announced the first hu","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1892829315.USD","BK4192","LU1989771016.USD","ONWRY","TILE","LU0266013472.USD","BK4232","BK4548","IDE","LU1291159041.SGD","BK4143","BK4082","BK4022","LU0077335932.USD","R","SCI","BCI","ARC"],"gpt_icon":0},{"id":"2544886989","title":"Press Release: VOYA GLOBAL ADVANTAGE AND PREMIUM OPPORTUNITY FUND & VOYA INFRASTRUCTURE, INDUSTRIALS AND MATERIALS FUND ANNOUNCES PAYMENT OF MONTHLY DISTRIBUTION","url":"https://stock-news.laohu8.com/highlight/detail?id=2544886989","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544886989?lang=en_us&edition=fundamental","pubTime":"2025-06-17 04:15","pubTimestamp":1750104900,"startTime":"0","endTime":"0","summary":"Voya Global Advantage and Premium Opportunity Fund  and Voya Infrastructure, Industrials and Materials Fund   today announced important information concerning the Funds' distributions declared in May 2025. This press release is issued as required by the Funds' Managed Distribution Plan  and an exemptive order received from the U.S. Securities and Exchange Commission. The Board of Trustees has approved the implementation of the Plan to make monthly cash distributions to common shareholders, stated in terms of a fixed amount per common share. This information is sent to you for informational purposes only and is an estimate of the sources of the June distribution. It is not determinative of the tax character of the Funds' distributions for the 2025 calendar year. Shareholders should note that the Funds' total regular distribution amount is subject to change as a result of market conditions or other factors.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","ARKG","IGA","IDE","FUND","LU0061475181.USD","BK4184","NAV","LU0211331839.USD","VOYA","BK4585","LU1878469433.USD","BK4544"],"gpt_icon":0},{"id":"2543278642","title":"Voya Infrastructure Industrials and Materials Fund Releases June 2025 Distribution Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2543278642","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543278642?lang=en_us&edition=fundamental","pubTime":"2025-06-16 13:24","pubTimestamp":1750051442,"startTime":"0","endTime":"0","summary":"Voya Infrastructure, Industrials and Materials Fund  announced its June 2025 distribution, set at $0.100 per common share, as part of its Managed Distribution Plan. The distribution is sourced mainly from net investment income, accounting for 29.31% of the current distribution. The fund has maintained an average annual total return of 11.96% at NAV over the past five years.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Voya Infrastructure Industrials and Materials Fund published the original content used to generate this news brief on June 16, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nNDL1bD7tX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDE"],"gpt_icon":0},{"id":"2536373266","title":"Press Release: Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2536373266","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536373266?lang=en_us&edition=fundamental","pubTime":"2025-05-20 04:01","pubTimestamp":1747684860,"startTime":"0","endTime":"0","summary":"- Interim Jan-2025 results from three trials of Alpha DaRT in treating pancreatic cancer shared at prestigious 2025 ASCO GI Symposium and R&D Update Day, showing >90% disease control rate, impressive overall survival in sub-group analyses, and positive safety profile -. - 75% systemic objective response rate  and 37.5% complete response rate meaningfully higher thus far than historical Keytruda monotherapy data in Jan-2025 interim read out of a combination trial of Alpha DaRT and Keytruda in head and neck squamous cell carcinoma  -. - FDA approval of Investigational Device Exemption  and IDE supplement to conduct a U.S. pilot study of Alpha DaRT together with first-line chemotherapy in patients with newly diagnosed locally advanced or metastatic pancreatic cancer -. - FDA approval of IDE to conduct a U.S. pilot study of Alpha DaRT in patients with recurrent glioblastoma multiforme , a highly aggressive brain cancer -","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRTS","BK4022","IDE","R","BK4082","BK4232","ORR"],"gpt_icon":0},{"id":"2535083698","title":"Press Release: VOYA GLOBAL ADVANTAGE AND PREMIUM OPPORTUNITY FUND & VOYA INFRASTRUCTURE, INDUSTRIALS AND MATERIALS FUND ANNOUNCES PAYMENT OF MONTHLY DISTRIBUTION","url":"https://stock-news.laohu8.com/highlight/detail?id=2535083698","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535083698?lang=en_us&edition=fundamental","pubTime":"2025-05-16 04:15","pubTimestamp":1747340100,"startTime":"0","endTime":"0","summary":"VOYA GLOBAL ADVANTAGE AND PREMIUM OPPORTUNITY FUND & VOYA INFRASTRUCTURE, INDUSTRIALS AND MATERIALS FUND ANNOUNCES PAYMENT OF MONTHLY DISTRIBUTION. Voya Global Advantage and Premium Opportunity Fund  and Voya Infrastructure, Industrials and Materials Fund   today announced important information concerning the Funds' distributions declared in April 2025. This press release is issued as required by the Funds' Managed Distribution Plan  and an exemptive order received from the U.S. Securities and Exchange Commission. The Board of Trustees has approved the implementation of the Plan to make monthly cash distributions to common shareholders, stated in terms of a fixed amount per common share. This information is sent to you for informational purposes only and is an estimate of the sources of the May distribution. It is not determinative of the tax character of the Funds' distributions for the 2025 calendar year. Shareholders should note that the Funds' total regular distribution amount is s","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1878469433.USD","NAV","VOYA","BK4184","FUND","LU0211331839.USD","IDE","ARKG","IGA","LU0061475181.USD"],"gpt_icon":0},{"id":"2533826582","title":"Artivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery (AATS) Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2533826582","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533826582?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:00","pubTimestamp":1746442800,"startTime":"0","endTime":"0","summary":"ATLANTA, May 5, 2025 /PRNewswire/ -- Artivion, Inc. ,a leading cardiac and vascular surgery company focused on aortic disease, today announced the presentation of new clinical data from Endospan's NEXUS TRIOMPHE trial at the 105th American Association for Thoracic Surgery  Annual Meeting in Seattle, Washington. The data presented analyzed clinical outcomes across a 54-patient chronic aortic dissection statistical cohort at 30 days following treatment with NEXUS. Patients enrolled were at high risk for open surgical repair.Dr. Bradley Leshnower, Professor of Surgery and Director of Thoracic Aortic Surgery, Emory University, presented the data from the NEXUS US IDE trial in an abstract titled, Endovascular Aortic Arch Repair Using a Novel Single-Branch Arch Stent Graft for Chronic Dissection: 30-Day Outcomes of the TRIOMPHE FDA Pivotal Study.The data demonstrate statistically significant improvement in clinical outcomes and device technical performance compared with the performance goals","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/artivion-announces-presentation-clinical-data-110000985.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/artivion-announces-presentation-clinical-data-110000985.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AFG","BK4082","BK4117","BK4107","IE00B19Z4B17.USD","AORT","IE00B7SZL793.SGD","IE00B66KJ199.SGD","IDE","IE0031619046.USD"],"gpt_icon":0},{"id":"2532740190","title":"Commemorative NFT Easter Eggs to be Minted After Successful Exhibition of Patented Data Vault® Experiential Data Display in Washington D.C.","url":"https://stock-news.laohu8.com/highlight/detail?id=2532740190","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532740190?lang=en_us&edition=fundamental","pubTime":"2025-05-01 20:35","pubTimestamp":1746102900,"startTime":"0","endTime":"0","summary":"- 47 3D Egg Experiences Enabled by Data Vault Teach about U.S. National Parks, Protected Endangered Species, Geography and American History -. BEAVERTON, Ore., May 01, 2025----Datavault AI Inc. , a trailblazer in data sciences and Web 3.0 asset monetization, proudly announces its innovative VerifyU team has minted three complete sets of 47 3D NFT eggs, which are displayed at www.databunny.us, immutably honoring the shared educational mission of both Datavault AI and the White House Historical Association to teach American history while supporting the association's mission of using technology to tell its stories through The People’s House.The experiential and educational NFT Eggs leverage DVHolo holographic display and ADIO cryptoanchor technologies used to authenticate the \"2025 Natural Heritage Preservation NFT Easter Egg Basket\" and engage Americans in learning about the nation’s National Natural Heritage. This initiative, showcased at the official White House Historical Association'","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/commemorative-nft-easter-eggs-minted-123500254.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4211","BK4141","WASH","IDE","DVLT"],"gpt_icon":0},{"id":"2532077870","title":"enVVeno Medical Reports First Quarter 2025 Financial Results and Reiterates Progress Toward VenoValve FDA Decision Expected in 2H24","url":"https://stock-news.laohu8.com/highlight/detail?id=2532077870","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532077870?lang=en_us&edition=fundamental","pubTime":"2025-05-01 20:05","pubTimestamp":1746101100,"startTime":"0","endTime":"0","summary":"Cash Burn of $4.0 million in Q1 remains in line with projected quarterly range. Cash and investments on hand are sufficient to fund operations beyond the anticipated FDA decision of VenoValve and the initiation of the enVVe pivotal trial. FDA decision on PMA application for the VenoValve expected in the second half of 2025. On track for enVVe IDE application submission in Q3 of 2025, pending GLP study results. Robert Berman, enVVeno Medical's Chief Executive Officer, commented \"In the first quarter, we continued to present our compelling 1-year data from the U.S. pivotal trial at leading global, scientific conferences to socialize and engage directly with leading vascular surgeons as we lay the foundation for the potential phased market entry of the VenoValve, pending FDA approval. We have also maintained a strong financial position - an important advantage in the current market conditions. We remain confident that 2025 will be a pivotal year as we prepare for our transition from a dev","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/envveno-medical-reports-first-quarter-120500690.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2065732104.USD","BK4097","BK4082","CVI","NVNO","BK4138","PRGS","IDE"],"gpt_icon":0},{"id":"2532078226","title":"BD Reports Second Quarter Fiscal 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2532078226","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532078226?lang=en_us&edition=fundamental","pubTime":"2025-05-01 18:30","pubTimestamp":1746095400,"startTime":"0","endTime":"0","summary":"Revenue of $5.3 billion increased 4.5% as reported, 6.0% currency-neutral and 0.9% organic. GAAP and adjusted diluted EPS of $1.07 and $3.35, respectively. Company updates full-year fiscal 2025 guidance and provides estimated tariff impact. FRANKLIN LAKES,N.J., May 1, 2025 /PRNewswire/ -- BD  , a leading global medical technology company, today announced results for its fiscal 2025 second quarter, which ended March31, 2025.\"Amid a difficult operating environment impacting near-term organic revenue growth, our Q2 results reflect the strength of our business model and ability to exceed our earnings expectations through quality gross margin improvement,\" said Tom Polen, chairman, CEO and president of BD. \"Our BD Excellence operating system is driving continued margin expansion and increasing investment in our commercial organization and innovation, and we believe we are well positioned to accelerate growth as markets recover. As we take decisive mitigation actions to navigate the current ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/bd-reports-second-quarter-fiscal-103000884.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bd-reports-second-quarter-fiscal-103000884.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","SM","BK4504","FXN","LU0511384066.AUD","LU0289739343.SGD","PI","LU1150488135.SGD","BK4139","IDE","LU0289961442.SGD","LU0068578508.USD","LU1059921491.USD","LU1150488218.USD","APM","BK4144","LU1854103824.USD","LU0266013472.USD","LU0433182093.SGD","LU1878469433.USD","UCC","LU1489326972.SGD","BK4588","BK4132","LU1894683264.USD","LU1894683348.USD","SURG","BK4141","MMS","LU0878866978.SGD","LU0985489474.SGD","LU1854104046.USD","BK4082","BK4581","BK4590","BK4226","LU0985320562.USD","BK4106","ET","LU1571399168.USD","IE00BFXG1179.USD","BK4213","BDX","BK4561"],"gpt_icon":0},{"id":"2531080066","title":"Datavault AI Stockholders’ Majority Approve Strategic Acquisition of CompuSystems, Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2531080066","media":"Business Wire","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531080066?lang=en_us&edition=fundamental","pubTime":"2025-04-30 18:35","pubTimestamp":1746009300,"startTime":"0","endTime":"0","summary":"CSI expected to contribute $15 million to $20 million of total revenue target of $40 million to $50 million in 2026. BEAVERTON, Ore., April 30, 2025----Datavault AI Inc. , leading the way in AI data experience, valuation and monetization, has a majority of stockholders’ votes needed to approve its strategic acquisition of CompuSystems, Inc.  and has mailed an Information Statement pursuant to Section 14 of the Securities Exchange Act of 1934 to Stockholders on April 29, 2025. The Information Statement concerns actions approved by Written Consent by the majority of the Company’s Stockholders, and no stockholder vote is required. Per SEC Rule 14c-2, these actions will take effect at least 20 days after mailing, or on or about the week of May 19, 2025.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/datavault-ai-stockholders-majority-approve-103500806.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["DVLT","BK4141","IDE"],"gpt_icon":0},{"id":"2530402168","title":"NFL Alumni Health Taps Datavault AI’s ADIO® for Health-Focused and Interactive Web 3.0 Activations During Draft Week Event","url":"https://stock-news.laohu8.com/highlight/detail?id=2530402168","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530402168?lang=en_us&edition=fundamental","pubTime":"2025-04-28 20:35","pubTimestamp":1745843700,"startTime":"0","endTime":"0","summary":"ADIO Tones Delivered AI-Powered Live Audience Engagement and Health Messaging During 2025 NFL Draft. Cardiovascular disease remains a critical issue among former NFL players, with studies showing significantly higher health risks compared to the general population. Research published in the Journal of the American College of Cardiology found that 89.8% of retired NFL athletes suffer from hypertension, yet only 37.5% are aware of their condition.1 In large-scale event environments, audience engagement often drops off sharply without compelling, interactive elements. ADIO addresses both challenges—enabling dynamic health messaging without reliance on visual or manual prompts while simultaneously demonstrating how key event milest","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nfl-alumni-health-taps-datavault-123500713.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IDE","DVLT","BK4141"],"gpt_icon":0},{"id":"2529060605","title":"Microchip Introduces PIC16F17576 MCU Family to Simplify Analog Sensor Design","url":"https://stock-news.laohu8.com/highlight/detail?id=2529060605","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529060605?lang=en_us&edition=fundamental","pubTime":"2025-04-23 19:03","pubTimestamp":1745406180,"startTime":"0","endTime":"0","summary":"Integrated low-power analog peripherals reduce design costs and complexity. CHANDLER, Ariz., April 23, 2025  -- Devices designed for capturing rapidly changing analog signals must respond quickly while consuming minimal power, especially in battery-operated applications. To address these demands, Microchip Technology  has released the PIC16F17576 microcontroller  product family with integrated low-power peripherals and the ability to precisely measure volatile analog signals.PIC16F17576 MCUs feature a new low-power comparator and voltage reference combination that can operate while the MCU core is in sleep mode, allowing for continuous analog measurement while consuming less than 3.0 A of current. The Analog Peripheral Manager  controls which peripherals are active to minimize total energy consumption and enable battery-operated applications to monitor signals effectively without excessive power drain.Engineered for applications that measure volatile analog signals, PIC16F17576 MCUs in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/microchip-introduces-pic16f17576-mcu-family-110300037.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4529","BK4139","MCHP","BK4604","LU0342679015.USD","LU0353189680.USD","LU1720051017.SGD","LU2087625088.SGD","BK4141","BK4605","MCHPP","LU0353189763.USD","LU1983260115.SGD","LU0348723411.USD","LU1720051108.HKD","BK4588","LU2357305700.SGD","APM","BK4512","IDE","LU1548497426.USD"],"gpt_icon":0},{"id":"2527206894","title":"Press Release: Voya Equity Closed End Funds Declare Distributions","url":"https://stock-news.laohu8.com/highlight/detail?id=2527206894","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527206894?lang=en_us&edition=fundamental","pubTime":"2025-04-16 04:30","pubTimestamp":1744749000,"startTime":"0","endTime":"0","summary":"Voya Investment Management, the asset management business of Voya Financial, Inc. , announced today the distributions on the common shares of five of its closed-end funds: Voya Global Advantage and Premium Opportunity Fund , Voya Global Equity Dividend and Premium Opportunity Fund , Voya Infrastructure, Industrials and Materials Fund , Voya Asia Pacific High Dividend Equity Income Fund , and Voya Emerging Markets High Dividend Equity Fund .With respect to each Fund, the distribution will be paid on May 15, 2025, to shareholders of record on May 1, 2025. The ex-dividend date is May 1, 2025. The distribution per share for each Fund is as follows:. The following table sets forth an estimate of the sources of each Fund's March distribution and its cumulative distributions paid this fiscal year to date. Amounts are expressed on a per common share basis and as a percentage of the distribution amount.Estimated Sources                             Fiscal YTD                          Estimated F","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDE","LU0211331839.USD","LU0061475181.USD","BK4184","BK4588","LU1878469433.USD","VOYA","BK4585","NAV","IGD","IAE","IHD","BK4022","BK4232","BK4215","IGA","R","EQR"],"gpt_icon":0},{"id":"2527427138","title":"Press Release: VOYA GLOBAL ADVANTAGE AND PREMIUM OPPORTUNITY FUND & VOYA INFRASTRUCTURE, INDUSTRIALS AND MATERIALS FUND ANNOUNCES PAYMENT OF MONTHLY DISTRIBUTION","url":"https://stock-news.laohu8.com/highlight/detail?id=2527427138","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527427138?lang=en_us&edition=fundamental","pubTime":"2025-04-16 04:15","pubTimestamp":1744748100,"startTime":"0","endTime":"0","summary":"Voya Global Advantage and Premium Opportunity Fund  and Voya Infrastructure, Industrials and Materials Fund   today announced important information concerning the Funds' distributions declared in March 2025. This press release is issued as required by the Funds' Managed Distribution Plan  and an exemptive order received from the U.S. Securities and Exchange Commission. The Board of Trustees has approved the implementation of the Plan to make monthly cash distributions to common shareholders, stated in terms of a fixed amount per common share. This information is sent to you for informational purposes only and is an estimate of the sources of the April distribution. It is not determinative of the tax character of the Funds' distributions for the 2025 calendar year. Shareholders should note that the Funds' total regular distribution amount is subject to change as a result of market conditions or other factors.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4184","BK4588","VOYA","IDE","BK4585","LU0211331839.USD","ARKG","NAV","BK4544","LU0061475181.USD","LU1878469433.USD","IGA","FUND"],"gpt_icon":0},{"id":"2527458761","title":"Comparative Analysis of Qubetics, SUI, and Binance Coin: Best Cryptos to Buy Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2527458761","media":"CoinMarketCap","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527458761?lang=en_us&edition=fundamental","pubTime":"2025-04-15 14:44","pubTimestamp":1744699487,"startTime":"0","endTime":"0","summary":"$TICS Presale Enters 30th Stage – One of the Best Crypto to Buy Right in Now Alongside SUI and Binance Coin for Massive Return Potential. Cryptocurrency enthusiasts are always on the lookout for the next big opportunity. In 2025, three projects have garnered significant attention: Qubetics , SUI, and Binance Coin . Each offers unique features and potential, making them prime candidates for those seeking the best crypto to buy in right now.As the digital finance landscape evolves, Qubetics  stands out by addressing real-world problems that its predecessors have struggled with. Its unique approach positions it to cater to the future needs of blockchain and digital finance, making it a compelling option for those seeking the best crypto to buy in right now.Qubetics is revolutionizing the blockchain space with its innovative features and impressive presale performance. Currently in its 30th presale stage, the project has raised over $16.1 million, with more than 508 million $TICS tokens so","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://coinmarketcap.com/community/articles/67fe0061d1c09208843921a2/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"coinmarketcap_highlight","symbols":["BK4228","TON.USD.CC","BK4215","SUI","APT.USD.CC","IDE","APT.USD.HKCC","TON.USD.HKCC"],"gpt_icon":0},{"id":"2524259801","title":"Datavault AI to Participate at the LD Micro Invitational XV","url":"https://stock-news.laohu8.com/highlight/detail?id=2524259801","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524259801?lang=en_us&edition=fundamental","pubTime":"2025-04-03 20:00","pubTimestamp":1743681600,"startTime":"0","endTime":"0","summary":"- Reminder: Investor business update call scheduled for today - April 3, 2025 at 11:00 am ET -. BEAVERTON, Ore., April 03, 2025----Datavault AI Inc. , leading the way in AI data experience, valuation, and monetization, today announced Datavault AI’s CEO Nathaniel Bradley and CFO Brett Moyer will participate at the LD Micro Invitational XV being held on April 9-10, 2025. In addition, as previously announced, Datavault AI will host a business update conference call today, April 3, 2025, at 11:00 AM ET, to discuss recent developments and initiatives.Those without internet access or who wish to dial in may call: 1-833-366-1124 , or 1-412-317-0702 . All callers should dial in approximately 10 minutes prior to the scheduled start time and ask to be joined into the Datavault AI call.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/datavault-ai-participate-ld-micro-120000143.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ML","DVLT","BK4141","IDE","BK4166","LD"],"gpt_icon":0},{"id":"2524249387","title":"Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2524249387","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524249387?lang=en_us&edition=fundamental","pubTime":"2025-04-02 20:30","pubTimestamp":1743597000,"startTime":"0","endTime":"0","summary":"JERUSALEM, April  02, 2025  (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, announced today that the FDA ha","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/02/3054239/0/en/Alpha-Tau-Receives-FDA-Approval-to-Initiate-a-Trial-for-Patients-with-Recurrent-Glioblastoma.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDE","BK4082","DRTS"],"gpt_icon":0},{"id":"2524116931","title":"ASE Demonstrates CPO that Improves Energy Efficiency for AI applications","url":"https://stock-news.laohu8.com/highlight/detail?id=2524116931","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524116931?lang=en_us&edition=fundamental","pubTime":"2025-04-01 21:00","pubTimestamp":1743512400,"startTime":"0","endTime":"0","summary":"SUNNYVALE, Calif., April 01, 2025----Advanced Semiconductor Engineering, Inc. , a member of ASE Technology Holding Co., Ltd. , today announced that it has demonstrated a co-packaged optics  device that mounts multiple optical engines  directly onto a substrate, enabling <5pJ/bit power consumption and significant bandwidth increases. With today’s processing power requirements being extremely amplified by AI pervasion, there is unprecedented demand for bandwidth that must be addressed. ASE’s new configuration enables crucial on-package energy efficiency and bandwidth expansion while addressing further data center challenges by delivering improvement related to latency, data throughput, and scalability.ASE’s CPO solves the assembly challenge of multiple optical engines with an ASIC in an integrated package with a large body configuration of >75mm X 75mm. The benefits for both the networking and data center markets are significant. For networking, it provides a potential option to improve ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ase-demonstrates-cpo-improves-energy-130000457.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4141","ASX","BK4543","IDE","BK4526"],"gpt_icon":0},{"id":"2524111166","title":"ABT Stock Gains Following the Positive TRILUMINATE Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2524111166","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524111166?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:22","pubTimestamp":1743506520,"startTime":"0","endTime":"0","summary":"Abbott Laboratories ABT recently unveiled favorable TRILUMINATE Pivotal trial data at the American College of Cardiology's Annual Scientific Session , held in Chicago. The data demonstrated Abbott’s TriClip transcatheter edge-to-edge repair  system’s ability to treat tricuspid regurgitation . The system showed substantial and sustained improvements in the severity of TR after two years.The TriClip system is also found to reduce the rate of hospitalizations due to heart failure compared to medical therapy while offering long-term quality-of-life benefits for patients. The latest development is expected to bolster the company’s Structural Heart business.Following yesterday's announcement, Abbott shares rose 1.4%, closing at $132.65.The company currently offers a comprehensive portfolio of structural heart solutions for a range of conditions, enabling patients to achieve better health and an improved quality of life. Moreover, Abbott is an established leader in TEER space with its MitraCl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/abt-stock-gains-following-positive-112200931.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1023059063.AUD","IE00B2B36J28.USD","LU0006061336.USD","LU0052756011.USD","LU0240878834.USD","LU1989763427.SGD","BK4592","LU2244417387.USD","LU1291159041.SGD","LU0823417653.USD","IDE","LU1267930490.SGD","BK4212","LU0072461881.USD","ABT","IE0009355771.USD","LU0154236417.USD","LU0353189680.USD","IE00BFTCPJ56.SGD","LU2362540622.SGD","LU0345769631.USD","LU0823416689.USD","LU0353189763.USD","BK4581","BK4504","LU2764263039.SGD","BSX","LU2764262908.HKD","TR","LU0882574055.USD","LU2506952097.USD","LU0345769128.USD","MASI","LU1791710400.SGD","LU2506952170.USD","LU0267386448.USD","BK4082","CAH","LU1989763690.USD","BK4568","LU0211327993.USD","SG9999004303.SGD","LU1989764664.SGD","LU0048584097.USD","LU0868494617.USD","LU1914381329.SGD","LU2506951958.HKD","LU2242649171.HKD"],"gpt_icon":0},{"id":"2524019416","title":"Fractyl Health Reports Positive Early Data Showing Revita® Has Potential to Prevent Weight Regain After GLP-1 Discontinuation","url":"https://stock-news.laohu8.com/highlight/detail?id=2524019416","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524019416?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:00","pubTimestamp":1743505200,"startTime":"0","endTime":"0","summary":"New REVEAL-1 study results show early signs of weight maintenance after GLP-1 discontinuation REMAIN-1 pivotal study now more than 50% enrolled; midpoint data analysis anticipated in Q3 2025 BURLINGTO","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/01/3053157/0/en/Fractyl-Health-Reports-Positive-Early-Data-Showing-Revita-Has-Potential-to-Prevent-Weight-Regain-After-GLP-1-Discontinuation.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLP","BK4082","GUTS","BK4590","BK4144","IDE"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":67,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDE\",params:#limit:5,,,undefined,":[{"date":"2025-07-01","symbol":"IDE","amount":0.1,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-07-01","defaultRemindTime":1751376600000,"name":"Voya Infrastructure Industrials and Materials Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-15","payableDate":"2025-07-01","currency":"USD","dateTimestamp":1751342400000,"payDate":"2025-07-15"},{"date":"2025-06-02","symbol":"IDE","amount":0.1,"announcedDate":"2025-05-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-02","defaultRemindTime":1748871000000,"name":"Voya Infrastructure Industrials and Materials Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-16","payableDate":"2025-06-02","currency":"USD","dateTimestamp":1748836800000,"payDate":"2025-06-16"},{"date":"2025-05-01","symbol":"IDE","amount":0.1,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-01","defaultRemindTime":1746106200000,"name":"Voya Infrastructure Industrials and Materials Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-15","payableDate":"2025-05-01","currency":"USD","dateTimestamp":1746072000000,"payDate":"2025-05-15"},{"date":"2025-04-01","symbol":"IDE","amount":0.1,"announcedDate":"2025-03-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-01","defaultRemindTime":1743514200000,"name":"Voya Infrastructure Industrials and Materials Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-15","payableDate":"2025-04-01","currency":"USD","dateTimestamp":1743480000000,"payDate":"2025-04-15"},{"date":"2025-03-03","symbol":"IDE","amount":0.1,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-03","defaultRemindTime":1741012200000,"name":"Voya Infrastructure Industrials and Materials Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-17","payableDate":"2025-03-03","currency":"USD","dateTimestamp":1740978000000,"payDate":"2025-03-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDE\",market:\"US\",,,undefined,":[{"executeDate":"2015-10-01","recordDate":"2015-10-05","paymentDate":"2015-10-15","value":0.365,"currency":"USD"},{"executeDate":"2015-12-29","recordDate":"2015-12-31","paymentDate":"2016-01-15","value":0.365,"currency":"USD"},{"executeDate":"2016-04-01","recordDate":"2016-04-05","paymentDate":"2016-04-15","value":0.365,"currency":"USD"},{"executeDate":"2016-07-01","recordDate":"2016-07-06","paymentDate":"2016-07-15","value":0.365,"currency":"USD"},{"executeDate":"2016-10-03","recordDate":"2016-10-05","paymentDate":"2016-10-17","value":0.365,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDE\",market:\"US\",delay:false,,,undefined,":{}}}